Third Joint Transnational Call (JTC 2016)

Basic Information

The third call of TRANSCAN-2 (JTC 2016) focuses on: “Minimally and non-invasive methods for early detection and/or progression of cancer”. Minimally invasive methods refer to techniques that have limited physical damage, burden and pain associated with the detection method, resulting in less anticipated stress, a higher screening/clinical care uptake, and more efficient and cost-effective screening and care. The studied methods should be sensitive for early detection of cancer, its staging and prediction of progression. Examples are: individual or combination of molecular, immunochemical, proteomic or genetic markers in body fluids and blood or cell samples, as well as macroscopic, microscopic and molecular imaging techniques (e.g. improved ultrasound technology, molecular imaging with contrast agents, fluorescence imaging, radiolabelling). This call excludes invasive methods, such as image-guided biopsy or surgery.

Network TRANSCAN-2
Website http://www.transcanfp7.eu/calls/third-joint-transnational-call-jtc-2016.html
Aim of the joint call The third call of TRANSCAN-2 (JTC 2016) focuses on: “Minimally and non-invasive methods for early detection and/or progression of cancer”. Minimally invasive methods refer to techniques that have limited physical damage, burden and pain associated with the detection method, resulting in less anticipated stress, a higher screening/clinical care uptake, and more efficient and cost-effective screening and care. The studied methods should be sensitive for early detection of cancer, its staging and prediction of progression. Examples are: individual or combination of molecular, immunochemical, proteomic or genetic markers in body fluids and blood or cell samples, as well as macroscopic, microscopic and molecular imaging techniques (e.g. improved ultrasound technology, molecular imaging with contrast agents, fluorescence imaging, radiolabelling). This call excludes invasive methods, such as image-guided biopsy or surgery.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 02/12/2016
Deadline Pre-Proposal 13/02/2017 Submitted proposal: 110
Deadline Full-Proposal 07/06/2017 Submitted proposal: 38
Evaluation End Date 01/10/2017 Successful proposal: n/a Proposals funded: 14
Is call co-funded? No
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
Participating networks n/a

Organisations Participating

Country Organisation
Estonian Research Council duplicate to 998483760
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
France ARC French foundation for Cancer Research (ARC-France)
France National Cancer Institute (INCa)
Germany Federal Ministry of Education and Research (BMBF)
Greece General Secretariat for Research and Technology (GSRT)
Israel Ministry of Health (CSO-MOH)
Italy Alliance Against Cancer (ACC)
Italy Lombardy Foundation for Biomedical Research (FRRB)
Italy Ministry of Health (MOH/MDS)
Latvia State Education Development Agency (VIAA)
Netherlands Dutch Cancer Society (KWF)
Norway Norwegian Cancer Society (NCS)
Norway Research Council of Norway (RCN)
Poland National Centre for Research and Development (NCBiR)
Slovakia Slovak Academy of Science (SAS/SAV)
Slovenia Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
Spain Foundation for Asturias Promotion of Applied Scientific Research and Technology (FICYT)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Taiwan MINISTRY OF SCIENCE AND TECHNOLOGY (MoST Taiwan)
Turkey The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
ABC-Cancer Airborne Biomarkers for Colorectal Cancer 4
BioEndoCar Biomarkers for diagnosis and prognosis of endometrial carcin... 6
CLEARLY Validation of multiparametric models and Circulating and ima... 7
ESCEND Detection of Early esophageal cancer by near-infrared fluore... 3
GLIOMA-PRD Multiparameric Analysis of the Evolution and Progression of ... 4
NIRBTEST New strategies to detect cancers in carriers of mutations in... 5
NOVEL Employing NGS technology for improved, non-invasive early de... 7
PROLIPSY Early Detection of Prostate Cancer by Liquid Biopsies 5
PROSCANEXO Exploitation of extracellular vesicles for precision diagnos... 5
RESTING Non-invasive prognostic markers for Resected Early-STage NSC... 3
SCRAtCH Microbiota-based screening of anal cancer in HIV-infected in... 5
THRuST Early detection of relapses in stage II-III colon cancer pat... 6
TRANSCALL2 Integration of genetic biomarkers and early Minimal Residual... 6
iMMunocell Single-cell immunophenotypic and transcriptomic profiling fo... 4